Isolated Clinic Normotension and Target Organ Pathology
Saturday, Dec 22 2007
Assuming that patients with isolated clinic normotension exhibit elevated blood pressures during most of their daily life (except when in the clinic of course!), it could be hypothesized that patients with these blood pressure profiles possess the same target organ pathology and elevated risk for cardiovascular disease as individuals with untreated essential hypertension.
Although a lot of data have not been gathered to test this hypothesis, the evidence that exists shows that isolated clinic normotensive patients indeed exhibit the same target organ pathology as patients with sustained essential hypertension (Liu et al., 1999; Sega et al., 2001). Liu et al. (1999) reported comparable indices of left ventricular hypertrophy and carotid artery atherosclerosis as well as numerous blood assays (glucose level, cholesterol level, creatinine concentration) between isolated clinic normotensive and essential hypertensive patients.
Both hypertensive groups exhibited a greater incidence of left ventricular hypertrophy, plaque development in the carotid arteries, and increased levels of serum glucose and cholesterol than normotensive controls, lending support to the hypothesis that isolated clinic normotension is associated with increased risk for cardiovascular disease consequences. By using data from the PAMELA Study, Sega et al. (2001) confirmed that isolated clinic normotension is not a benign condition. As in the aforementioned findings reported by Liu et al., isolated clinic normotensive patients exhibited greater left ventricular hypertrophy than persons with normal blood pressures in all settings.
Although not many studies have examined target organ pathology in isolated clinic normotension, and no studies have yet examined the relation between actual cardiovascular disease endpoints in isolated clinic normotension, the current evidence indicates that individuals with this unique blood pressure profile exhibit risk for cardiovascular complications comparable to untreated essential hypertensive patients. In a sense, that is what they are.
Manuck, S. B., Kasprowicz, A. L., Monroe, S. M., Larkin, K. T., and Kaplan, J. R.
Published with assistance from the foundation established in memory of Amasa Stone Mather of the Class of 1907, Yale College.
- Abel, J. A., and Larkin, K. T. (1991). Assessment of cardiovascular reactivity across laboratory and natural settings. Journal of Psychosomatic Research, 35, 365 - 373.
- Achmon, J., Granek, M., Golomb, M., and Hart, J. (1989). Behavioral treatment of essential hypertension: A comparison between cognitive therapy and biofeedback of heart rate. Psychosomatic Medicine, 51, 152 - 164.
- Agras, W. S., Horne, M., and Taylor, C. B. (1982). Expectation and the blood-pressure-lowering effects of relaxation. Psychosomatic Medicine, 44, 389 - 395.
- Agras, W. S., Taylor, C. B., Kraemer, H. C., Southam, M. A., and Schneider, J. A. (1987). Relaxation training for essential hypertension at the worksite: II. The poorly controlled hypertensive. Psychosomatic Medicine, 49, 264 - 273.
- Aivazyan, T. A., Zaitsev, V. P., Khramelashvili, V. V., Golenov, E. V., and Kichkin, V. I. (1988). Psychophysiological interrelations and reactivity characteristics in hypertensives. Health Psychology, 7, 137 - 144.
- al'Absi, M., and Wittmers, L. E. (2003). Enhanced adrenocortical responses to stress in hypertension-prone men and women. Annals of Behavioral Medicine, 25, 52 - 33.
- Albright, C. L., Winkleby, M. A., Ragland, D. R., Fisher, J., and Syme, S. L. (1992). Job strain and prevalence of hypertension in a biracial population of urban bus drivers. American Journal of Public Health, 82, 984 - 989.
- Davidyan, A. (1989). Emotional factors in essential hypertension. Psychosomatic Medicine, 55, 505 - 517.
- Alfredsson, L., Davidyan, A., Fransson, E., de Faire, U., Hallqvist, J., Knutsson, A., et al. (2002). Job strain and major risk factors for coronary heart disease among employed males and females in a Swedish study on work, lipids, and fibrinogen. Scandinavian Journal of Work, Environment and Health, 28, 238 - 248.
Last revised: by Dr. Shirak Vaishnian, M.D.
Provided by Armina Hypertension Association
Also in this section
- Caffeine-Heavy Energy Drinks Give Jolt to Blood Glucose
- ESC: Entresto for Hypertension? Yes!
- Best and safest blood pressure treatments in kidney and diabetes patients compiled
- Adverse childhood events appear to increase the risk of being a hypertensive adult
- An antihypertensive drug improves corticosteroid-based skin treatments
- Energy drinks raise resting blood pressure
- Large study of hypertension patients highlights key moments at which to intervene
- Hydrogen sulfide could help lower blood pressure
- New Guidelines: Treat Obesity First
- Stroke Rounds: Aspirin Overused for Primary Prevention
- Understanding Dementia
- Alzheimer’s Disease Stages
Post a comment [ + Comment here + ]
There are no comments for this entry yet. [ + Comment here + ]
Comments are moderated by our editors, so there may be a delay between submission and publication of your comment. Offensive or abusive comments will not be published.